Cardiovascular diseases are the leading cause of mortality across the world. According to statistics, 30% of deaths (approximately 17.3 million deaths per year) and 330 million disabilities per year are caused by cardiovascular diseases (
1). The prevalence of heart failure due to cardiovascular diseases has been reported to be 5.8 million per year in the United States and 23 million in the world (
2). Moreover, the associated five-year mortality has been reported to be higher than 75%, which is a major health concern after the first hospitalization (
3).
Cardiovascular diseases are a major cause of mortality in Iran, which impose significant costs on the healthcare system of the country each year. According to the statistics in Iran, the prevalence of coronary artery disease and the associated mortality is on the rise. In 2001, 317 and 116,000 patients died due to cardiovascular diseases in Iran per day and year, respectively (
4). Despite the advancement in invasive treatments such as coronary artery bypass grafting (CABG) and angioplasty, the mortality rate of cardiovascular diseases remains high in the patients.
Exercise-based cardiovascular rehabilitation (CR) could reduce cardiovascular mortality by 25% - 50% as an important component of the comprehensive program for the secondary prevention of cardiac diseases (
5). In general, CR could decrease cardiovascular mortality with targeted efforts focused on physical exercise, lipid control, hypertension control, and smoking cessation (
4). However, use of rehabilitation services is less common compared to the expected rate, and various data in the United States are indicative of the participation of only 31% of the patients undergoing CABG in CR programs. This rate has been estimated to be less than 15% in Iran, and a major cause of this issue is the lack of proper knowledge regarding the beneficial therapeutic effects of CR (
5). It is also notable that heart failure caused by cardiac surgeries has been overlooked in CR programs (
6,
7). Therefore, it is essential to determine the influential factors in the prognosis of these patients.
Heart failure is often induced by ischemia and myocardial infarction, and ischemia caused by the process of atherosclerosis has been recognized as a multistage inflammatory disease. Several environmental and hereditary factors affect the involvement of inflammatory cytokines, such as obesity, diabetes, and fat deficiency (
8). In this regard, the most commonly assessed inflammatory markers include interleukin 6 (IL-6) and high‐sensitivity C‐reactive protein (hsCRP) (
9,
10). CRP is produced by hepatocytes and is regulated by IL-6, and these agents are found in the endothelium of the atherosclerotic plaques, acting based on the changes in access to nitric oxide and leading to the onset and progression of atherosclerosis through the increased adhesion of inflammatory cells to the endothelium (
11). Several studies have indicated that increased cytokines (especially IL-6) could severely modify the cardiac function, thereby damaging myocytes. Furthermore, increased plasma IL-6 levels are significantly associated with left ventricular dysfunction and play a pivotal role in the progression of cardiac failure. Given the importance of these markers in the pathophysiology of cardiac failure, the positive effects of exercise training have been highlighted in various populations, which result in diminishing the effects of the mentioned factors on cardiovascular diseases (
12).
The international studies in this regard have demonstrated the effects of CR on hsCRP and IL-6 (
12-
14), proposing contradictory findings (
15-
20). Moreover, similar research has been performed at the Cardiac Rehabilitation Center of Imam Ali Hospital in Kermanshah, Iran, which has been mainly focused on exercise performance and lipid profiles.